Shape Memory Medical Inc. is dedicated to developing innovative therapeutic solutions with its proprietary shape memory polymers for endovascular markets. With devices approved in more than 25 countries spanning regions in Asia, the Middle East, Europe, the Americas and Australia, we are the first medical device company to introduce an FDA-cleared medical device utilizing shape memory polymer (SMP) technology to a vascular market.
Location: United States, California, Santa Clara
Employees: 11-50
Total raised: $38M
Founded date: 2009
Investors 3
| Date | Name | Website |
| 19.03.2024 | Earlybird ... | earlybird.... |
| - | Emergent M... | emvllp.com |
| - | HBM Partne... | hbmpartner... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.03.2024 | Series C | $38M | - |
Mentions in press and media 7
| Date | Title | Description |
| 29.10.2025 | Earlybird Health promotes two new partners as firm deepens biotech and analytics focus | Life sciences investor Earlybird Health has promoted Dr. Rabab Nasrallah and Dr. Christoph Massner to Partners. Both new partners have led the firm's strategy across biotech, data-enabled therapeutics and medtech. Earlybird Health, part of ... |
| 09.03.2024 | Shape Memory Medical: Revolutionizing Endovascular Treatments | Shape Memory Medical, a pioneer in custom shape memory polymers for endovascular applications, has secured a massive $38 million in Series C funding. The financing, spearheaded by Earlybird Venture Capital, signifies a major milestone for t... |
| 04.03.2024 | Shape Memory Medical Closes $38M Series C Financing | Shape Memory Medical Inc., a Santa Clara, Calif.-based developer of custom shape memory polymers for endovascular markets, completed a $38m Series C financing. The round was led by Earlybird Venture Capital with participation from new and e... |
| 04.03.2024 | Shape Memory Medical Completes $38 Million in Series C | SANTA CLARA, CA, Shape Memory Medical, a developer of custom shape memory polymers for endovascular markets, announced that it has completed $38 million in Series C financing. >> Click here for more funding data on Shape Memory Med... |
| 10.03.2021 | Shape Memory Medical Receives CE Mark for IMPEDE-FX RapidFill | SANTA CLARA, Calif.--(BUSINESS WIRE)--Mar 10, 2021-- Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced CE Mark Approval for the IMPEDE-FX RapidFill™ Device, an expansion of ... |
| - | Shape Memory Medical | “Smart polymer. Smart embolization. Smart choice. Reshaping your view of clinical success through the science of smart polymer.” |
| - | Shape Memory Medical: Endovascular Embolization Company Raises $38 Million | Shape Memory Medical – a developer of custom shape memory polymers for endovascular markets – announced that it has completed $38 million in Series C financing led by Earlybird Venture Capital and with the participation of new and existing ... |